Teligent Cites Remediation-Related Activites For Poor Quarter

As Company Recalls Lidocaine Anesthetic Solution Due To Super Potency

 
• By Akriti Seth
  
FDA
Teligent looks to remediate FDA warning letter in order to strengthen its injectables business • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products